115 related articles for article (PubMed ID: 17223228)
1. NPY receptors in human cancer: a review of current knowledge.
Körner M; Reubi JC
Peptides; 2007 Feb; 28(2):419-25. PubMed ID: 17223228
[TBL] [Abstract][Full Text] [Related]
2. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
Körner M; Reubi JC
J Neuropathol Exp Neurol; 2008 Aug; 67(8):741-9. PubMed ID: 18648328
[TBL] [Abstract][Full Text] [Related]
4. High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2004 Dec; 10(24):8426-33. PubMed ID: 15623622
[TBL] [Abstract][Full Text] [Related]
5. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting.
Reubi C; Gugger M; Waser B
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):855-62. PubMed ID: 12111125
[TBL] [Abstract][Full Text] [Related]
6. High expression of NPY receptors in the human testis.
Körner M; Waser B; Thalmann GN; Reubii JC
Mol Cell Endocrinol; 2011 Apr; 337(1-2):62-70. PubMed ID: 21295110
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y receptors in renal cell carcinomas and nephroblastomas.
Körner M; Waser B; Reubi JC
Int J Cancer; 2005 Jul; 115(5):734-41. PubMed ID: 15704095
[TBL] [Abstract][Full Text] [Related]
8. Identification of neuropeptide Y cleavage products in human blood to improve metabolic stability.
Khan IU; Reppich R; Beck-Sickinger AG
Biopolymers; 2007; 88(2):182-9. PubMed ID: 17206650
[TBL] [Abstract][Full Text] [Related]
9. Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.
Reubi JC; Gugger M; Waser B; Schaer JC
Cancer Res; 2001 Jun; 61(11):4636-41. PubMed ID: 11389101
[TBL] [Abstract][Full Text] [Related]
10. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
Gehlert DR; Shaw JL
Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y2 receptors as drug targets for the central regulation of body weight.
Félétou M; Levens NR
Curr Opin Investig Drugs; 2005 Oct; 6(10):1002-11. PubMed ID: 16259221
[TBL] [Abstract][Full Text] [Related]
12. Role of neuropeptide Y and its receptors in the progression of endocrine-related cancer.
Ruscica M; Dozio E; Motta M; Magni P
Peptides; 2007 Feb; 28(2):426-34. PubMed ID: 17204352
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y receptor expression in human primary ovarian neoplasms.
Körner M; Waser B; Reubi JC
Lab Invest; 2004 Jan; 84(1):71-80. PubMed ID: 14631382
[TBL] [Abstract][Full Text] [Related]
14. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications.
Fleischmann A; Waser B; Reubi JC
Endocr Relat Cancer; 2009 Jun; 16(2):623-33. PubMed ID: 19478282
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
Umeda T; Kanatani A; Iwaasa H
Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
[TBL] [Abstract][Full Text] [Related]
16. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors.
Teixeira L; Sousa DM; Nunes AF; Sousa MM; Herzog H; Lamghari M
J Cell Biochem; 2009 Aug; 107(5):908-16. PubMed ID: 19459152
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y Y1 receptor in human dental pulp cells of noncarious and carious teeth.
El Karim IA; Lamey PJ; Linden GJ; Lundy FT
Int Endod J; 2008 Oct; 41(10):850-5. PubMed ID: 18699789
[TBL] [Abstract][Full Text] [Related]
19. Self-regulation of agonist activity at the Y receptors.
Parker SL; Parker MS; Sah R; Balasubramaniam A; Sallee FR
Peptides; 2007 Feb; 28(2):203-13. PubMed ID: 17194507
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
Gehlert DR; Schober DA; Morin M; Berglund MM
Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]